RxDoctor Payments DataLook up a doctor →

Wail Asfour, MD

Cardiovascular Disease · Munster, INNPI 1720038680

Payments from drug & device makers

$736,260in general payments, 2019–2025

Across 1,028 payments — averaging $716.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim International GmbH$367K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$247K
  • Medtronic$33K
  • Kowa Research Institute, Inc.$27K
  • AstraZeneca$24K
  • Bard Peripheral Vascular, Inc.$6K
  • plus $33K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boehringer Ingelheim International GmbH177$366,707
Boehringer Ingelheim Pharma GmbH & Co.kg25$246,798
Medtronic(3 entities)144$32,573
Kowa Research Institute, Inc.24$27,112
AstraZeneca11$24,223
Bard Peripheral Vascular, Inc.25$5,537
Philips North America LLC39$5,038
Abbott45$4,467
Penumbra, Inc.11$3,634
Cordis US CORP.17$2,931
Boston Scientific38$2,680
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)53$2,471
Abiomed12$2,089
Novartis124$1,659
Cardiovascular Systems Inc.68$1,453
Surmodics, Inc.6$870
Angiodynamics, Inc.11$645
Cook Medical LLC18$612
Johnson & Johnson23$511
Inari Medical, Inc.20$449
Endologix LLC2$419
Boehringer Ingelheim13$290
Amgen13$278
Shockwave Medical, Inc3$241
Novo Nordisk10$196
Sanofi-aventis U.S. LLC12$179
Teleflex LLC2$178
Kestra Medical Technology Services, Inc.5$172
Cardiva Medical, Inc.7$142
Cardinal Health 200 LLC1$118
Atricure, Inc.1$107
Heartflow, Inc.3$106
Cequr Corporation1$103
Chiesi USA, Inc.7$103
Merck6$91
Baxter Healthcare2$79
Dexcom, Inc.1$75
Biotronik Inc.4$69
Catheter Precision, Inc. FKA Ra Medical Systems, Inc.2$69
Pfizer3$59
Tactile Systems Technology Inc3$58
Alnylam Pharmaceuticals Inc.2$55
Esperion Therapeutics, Inc.3$53
Kiniksa Pharmaceuticals International, PLC3$52
Edwards Lifesciences3$48
Endotronix, Inc.1$45
E.r. Squibb & Sons, L.L.C.3$44
Vifor Pharma, Inc.2$43
Regeneron Healthcare Solutions, Inc.2$42
Actelion Pharmaceuticals US, Inc.2$34
Lexicon Pharmaceuticals, Inc.2$31
Lundbeck LLC2$28
Almatica Pharma LLC1$25
Imperative Care, Inc1$23
Organogenesis Inc.1$20
Terumo Medical Corporation1$19
W. L. Gore & Associates, Inc.1$19
Idorsia Pharmaceuticals US Inc1$18
Scpharmaceuticals Inc.1$17
Akcea Therapeutics, Inc.1$16

How this compares

$736,260 in reported general payments places this provider in the 95th percentile of 408 cardiovascular disease providers in Indiana.

See all cardiovascular disease providers in Indiana →

Medicare billing

Part B allowed, 2024
$1,155,663
Medicare patients
998
Services billed
10,488

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Munster

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →